<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04883099</url>
  </required_header>
  <id_info>
    <org_study_id>LEN101</org_study_id>
    <nct_id>NCT04883099</nct_id>
  </id_info>
  <brief_title>APIOC for Presbyopia and APIOC for Presbyopia With Astigmatism</brief_title>
  <official_title>7 Day Trial of APIOC for Presbyopia and APIOC for Presbyopia With Astigmatism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lentechs, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lentechs, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vision and comfort, both objective and subjective, will be assessed for single vision contact&#xD;
      lens wearers for either the APIOC™ for Presbyopia or the APIOC™ for Presbyopia Astigmatism&#xD;
      contact lenses.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 6, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity Distance</measure>
    <time_frame>Day 7</time_frame>
    <description>High and Low Contrast LogMAR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Vision Quality</measure>
    <time_frame>Day 7</time_frame>
    <description>Visual analogue scale (0-100 points) 100 is best possible quality of vision</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>Day 7</time_frame>
    <description>Visual analogue scale(0-100 points) 100 is best possible comfort</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity Near</measure>
    <time_frame>Day 7</time_frame>
    <description>High and Low Contrast</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity Intermediate</measure>
    <time_frame>Day 7</time_frame>
    <description>High and Low Contrast</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective Comfort</measure>
    <time_frame>Day 7</time_frame>
    <description>Compared to habitual lenses, rated as better/same/worse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective vision Comparison</measure>
    <time_frame>Day 7</time_frame>
    <description>Compared to habitual lenses, rated as better/same/worse</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Presbyopia</condition>
  <condition>Myopia</condition>
  <condition>Hyperopia</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>APIOC for Presbyopia and Presbyopia with Astigmatism</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Presbyopic Spherical or Toric Contact Lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>APIOC for Presbyopia and APIOC for Presbyopia for Astigmatism</intervention_name>
    <description>Contact Lenses for Presbyopia</description>
    <arm_group_label>APIOC for Presbyopia and Presbyopia with Astigmatism</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The subject must provide written informed consent.&#xD;
&#xD;
          2. The subject must appear willing and able to adhere to the instructions set forth in&#xD;
             this protocol.&#xD;
&#xD;
          3. At least 40 years of age and no more than 70 years of age.&#xD;
&#xD;
          4. ≤ 4.00 D of corneal astigmatism.&#xD;
&#xD;
          5. ≤ 2.50 D of refractive astigmatism.&#xD;
&#xD;
          6. Refractive error range +4.00 DS to -6.00 DS&#xD;
&#xD;
          7. Require a reading addition (bifocal) of at least 0.75 D&#xD;
&#xD;
          8. Flat and steep keratometry readings within 40 to 48 D.&#xD;
&#xD;
          9. Clear, healthy corneas with no irregular astigmatism.&#xD;
&#xD;
         10. Normal, healthy conjunctiva in both eyes.&#xD;
&#xD;
         11. Free of active ocular disease. Refractive error and presbyopia are permitted.&#xD;
&#xD;
         12. Be a current or former (within the last 3 years) contact lens wearer.&#xD;
&#xD;
         13. Best-corrected near and distance visual acuity better than or equal to 20/25.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Irregular corneal astigmatism.&#xD;
&#xD;
          2. Corneal scarring unless off line-of-site and well healed.&#xD;
&#xD;
          3. Pinguecula, pterygium, or other conjunctival thickness abnormalities that would&#xD;
             interfere with soft contact lens wear.&#xD;
&#xD;
          4. Recent use of any ocular pharmaceutical treatments, including daily artificial tears,&#xD;
             in the two weeks prior to the examination. Occasional artificial tear use is&#xD;
             permitted.&#xD;
&#xD;
          5. Systemic disease that would interfere with contact lens wear.&#xD;
&#xD;
          6. Currently pregnant or lactating (by self-report).&#xD;
&#xD;
          7. History of strabismus or eye movement disorder, including exophoria at near that is 4&#xD;
             D or greater than at far, and a receded near point of convergence break that is 6 cm&#xD;
             or greater.&#xD;
&#xD;
          8. Active allergies that may inhibit contact lens wear.&#xD;
&#xD;
          9. Upper eyelid margin at or above the superior limbus.&#xD;
&#xD;
         10. History of ocular or lid surgery.&#xD;
&#xD;
         11. Immediate family members or significant others of doctors or staff at the clinical&#xD;
             site.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Quinn, OD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Athens Eye Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melissa Bailey, OD, PhD</last_name>
    <phone>614-625-6965</phone>
    <email>mbailey@lentechs.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jayne Frilling</last_name>
    <email>jfrilling@lentechs.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Complete Family Vision Care</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric White, OD</last_name>
      <phone>858-278-4720</phone>
      <email>sharon@drericwhite.com</email>
    </contact>
    <investigator>
      <last_name>Eric White, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eola Eyes</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kerry Giedd, OD,MS</last_name>
      <phone>407-447-7739</phone>
      <email>eolaeyes.study@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Kerry Giedd, OD,MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gaddie Eye Centers</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40517</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christy Douglas</last_name>
      <phone>859-278-9393</phone>
      <email>christy.douglas@kyeye.com</email>
    </contact>
    <investigator>
      <last_name>Paul Karpecki, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Miamisburg Vision Care</name>
      <address>
        <city>Miamisburg</city>
        <state>Ohio</state>
        <zip>45342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keith Basinger, OD</last_name>
      <phone>937-866-3471</phone>
      <email>mbailey@lentechs.com</email>
    </contact>
    <investigator>
      <last_name>Keith Basinger, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vision Professionals</name>
      <address>
        <city>New Albany</city>
        <state>Ohio</state>
        <zip>43054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tawni Cashon, OD</last_name>
      <phone>614-855-7574</phone>
      <email>mbailey@lentechs.com</email>
    </contact>
    <investigator>
      <last_name>Chris Smiley, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tawni Cashon, OD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eyecare Professionals of Powell</name>
      <address>
        <city>Powell</city>
        <state>Ohio</state>
        <zip>43065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Smith</last_name>
      <phone>614-793-0700</phone>
      <email>manager@eyecarepowell.com</email>
    </contact>
    <investigator>
      <last_name>Jason Miller, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 4, 2021</study_first_submitted>
  <study_first_submitted_qc>May 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2021</study_first_posted>
  <last_update_submitted>May 12, 2021</last_update_submitted>
  <last_update_submitted_qc>May 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Presbyopia</mesh_term>
    <mesh_term>Hyperopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No sharing of data is planned.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

